119 related articles for article (PubMed ID: 10329814)
1. Effect of intravenous immunoglobulin on steroid consumption in patients with severe asthma: a double-blind, placebo-controlled, randomized trial.
Salmun LM; Barlan I; Wolf HM; Eibl M; Twarog FJ; Geha RS; Schneider LC
J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):810-5. PubMed ID: 10329814
[TBL] [Abstract][Full Text] [Related]
2. A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma.
Kishiyama JL; Valacer D; Cunningham-Rundles C; Sperber K; Richmond GW; Abramson S; Glovsky M; Stiehm R; Stocks J; Rosenberg L; Shames RS; Corn B; Shearer WT; Bacot B; DiMaio M; Tonetta S; Adelman DC
Clin Immunol; 1999 May; 91(2):126-33. PubMed ID: 10227804
[TBL] [Abstract][Full Text] [Related]
3. Role of intravenous immunoglobulin in severe steroid-dependent asthma.
Haque S; Boyce N; Thien FC; O'Hehir RE; Douglass J
Intern Med J; 2003 Aug; 33(8):341-4. PubMed ID: 12895163
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of glucocorticoid reduction in asthmatic subjects treated with intravenous immunoglobulin.
Spahn JD; Leung DY; Chan MT; Szefler SJ; Gelfand EW
J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):421-6. PubMed ID: 10069875
[TBL] [Abstract][Full Text] [Related]
5. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).
Milgrom H; Berger W; Nayak A; Gupta N; Pollard S; McAlary M; Taylor AF; Rohane P
Pediatrics; 2001 Aug; 108(2):E36. PubMed ID: 11483846
[TBL] [Abstract][Full Text] [Related]
6. Comparison of oral-steroid sparing by high-dose and low-dose inhaled steroid in maintenance treatment of severe asthma.
Hummel S; Lehtonen L
Lancet; 1992 Dec 19-26; 340(8834-8835):1483-7. PubMed ID: 1361594
[TBL] [Abstract][Full Text] [Related]
7. Slight steroid-sparing effect of intravenous immunoglobulin in children and adolescents with moderately severe bronchial asthma.
Jakobsson T; Croner S; Kjellman NI; Pettersson A; Vassella C; Björkstén B
Allergy; 1994 Jul; 49(6):413-20. PubMed ID: 8074263
[TBL] [Abstract][Full Text] [Related]
8. A placebo-controlled multicenter study of auranofin in the treatment of patients with corticosteroid-dependent asthma. Auranofin Multicenter Drug Trial.
Bernstein IL; Bernstein DI; Dubb JW; Faiferman I; Wallin B
J Allergy Clin Immunol; 1996 Aug; 98(2):317-24. PubMed ID: 8757209
[TBL] [Abstract][Full Text] [Related]
9. Exhaled nitric oxide in children with asthma receiving Xolair (omalizumab), a monoclonal anti-immunoglobulin E antibody.
Silkoff PE; Romero FA; Gupta N; Townley RG; Milgrom H
Pediatrics; 2004 Apr; 113(4):e308-12. PubMed ID: 15060258
[TBL] [Abstract][Full Text] [Related]
10. [Inhaled corticotherapy sparing effect by sodium nedocromil in moderate to severe asthma].
Murciano D; Braunstein G; Montagut A; Pariente R
Rev Mal Respir; 1994; 11(5):485-92. PubMed ID: 7816992
[TBL] [Abstract][Full Text] [Related]
11. Benefits of high-dose i.v. immunoglobulin in patients with severe steroid-dependent asthma.
Landwehr LP; Jeppson JD; Katlan MG; Esterl B; McCormick D; Hamilos DL; Gelfand EW
Chest; 1998 Nov; 114(5):1349-56. PubMed ID: 9824013
[TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study.
Hahn AF; Bolton CF; Zochodne D; Feasby TE
Brain; 1996 Aug; 119 ( Pt 4)():1067-77. PubMed ID: 8813271
[TBL] [Abstract][Full Text] [Related]
13. An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma.
Mazer BD; Gelfand EW
J Allergy Clin Immunol; 1991 May; 87(5):976-83. PubMed ID: 2026848
[TBL] [Abstract][Full Text] [Related]
14. [Preliminary estimation of results of high-dose intravenous immunoglobulin in severe steroid-dependent adult asthma].
Kłos K; Kruszewski J
Pol Merkur Lekarski; 2001 Nov; 11(65):379-83. PubMed ID: 11852803
[TBL] [Abstract][Full Text] [Related]
15. Azathioprine as an oral corticosteroid sparing agent for asthma.
Dean T; Dewey A; Bara A; Lasserson TJ; Walters EH
Cochrane Database Syst Rev; 2004; (1):CD003270. PubMed ID: 14974011
[TBL] [Abstract][Full Text] [Related]
16. Benefits of low weekly doses of methotrexate in steroid-dependent asthmatic patients. A double-blind, randomized, placebo-controlled study.
Comet R; Domingo C; Larrosa M; Morón A; Rué M; Amengual MJ; Marín A
Respir Med; 2006 Mar; 100(3):411-9. PubMed ID: 16099632
[TBL] [Abstract][Full Text] [Related]
17. Auranofin in the treatment of steroid dependent asthma: a double blind study.
Nierop G; Gijzel WP; Bel EH; Zwinderman AH; Dijkman JH
Thorax; 1992 May; 47(5):349-54. PubMed ID: 1609377
[TBL] [Abstract][Full Text] [Related]
18. Anti-IgE for chronic asthma in adults and children.
Walker S; Monteil M; Phelan K; Lasserson TJ; Walters EH
Cochrane Database Syst Rev; 2004; (3):CD003559. PubMed ID: 15266491
[TBL] [Abstract][Full Text] [Related]
19. Minocycline treatment results in reduced oral steroid requirements in adult asthma.
Daoud A; Gloria CJ; Taningco G; Hammerschlag MR; Weiss S; Gelling M; Roblin PM; Joks R
Allergy Asthma Proc; 2008; 29(3):286-94. PubMed ID: 18534087
[TBL] [Abstract][Full Text] [Related]
20. Oral glucocorticosteroid-sparing effect of budesonide administered by Turbuhaler: a double-blind, placebo-controlled study in adults with moderate-to-severe chronic asthma. Pulmicort Turbuhaler Study Group.
Nelson HS; Bernstein IL; Fink J; Edwards TB; Spector SL; Storms WW; Tashkin DP
Chest; 1998 May; 113(5):1264-71. PubMed ID: 9596304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
